Joint UK NEQAS (BTLP) and BBTS Blood Bank Technology SIG Annual meeting
*UPDATE* Meeting Registration is now open and can be accessed here.
The Joint UK NEQAS (BTLP) and BBTS Blood Bank Technology SIG Annual meeting will be held on Tuesday 28 November 2017 in the National Convention Centre (National Motorcycle Museum), Birmingham.
Prior to the meeting there will be a delegate dinner on Monday 27 November in the Windmill Village Hotel.
'UK NEQAS: Coordinating Point of Care Testing' programme and registration form is now available
The programme and registration form is now available, for the one-day meeting
'UK NEQAS: Coordinating Point of Care Testing' at the prestigious Queen Elizabeth II Centre in Westminster, London on Friday 20th October 2017, with
exhibition stands from companies representing the POCT diagnostics industry. The programme and registration form can be accessed here.
Suppliers of G6PD assay reagents 06/07/2017 UPDATE
A field notice is available on the UK NEQAS Haematology website giving information on possible alternative suppliers of G6PD assay reagents.
This document can be accessed here.
Please note that the supply of G6PD screening kits is not affected and these remain available from Trinity Biotech.
An updated version of the information on alternative G6PD assay kit suppliers is available (uploaded on 07/07/2017), with additional companies.
The UK NEQAS Haematology Annual Report to Participants January – December 2016 is now available
The Annual Report to Participants January – December 2016 is now available and can be downloaded in the "Documents" section of this website or
We have recently increased our security and because we will now allow you to set your own passwords, we have hashed the passwords in our database which means they are no longer visible to us. Current passwords are now case sensitive and must match exactly to the password originally provided.
If you have forgotten your password or now you are unable to log in please use the “Reset my password” facility which is explained in further detail here.